1. Home
  2. MNKD vs ALEX Comparison

MNKD vs ALEX Comparison

Compare MNKD & ALEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNKD
  • ALEX
  • Stock Information
  • Founded
  • MNKD 1991
  • ALEX 1870
  • Country
  • MNKD United States
  • ALEX United States
  • Employees
  • MNKD N/A
  • ALEX N/A
  • Industry
  • MNKD Biotechnology: Pharmaceutical Preparations
  • ALEX Real Estate Investment Trusts
  • Sector
  • MNKD Health Care
  • ALEX Real Estate
  • Exchange
  • MNKD Nasdaq
  • ALEX Nasdaq
  • Market Cap
  • MNKD 1.2B
  • ALEX 1.3B
  • IPO Year
  • MNKD 2004
  • ALEX N/A
  • Fundamental
  • Price
  • MNKD $3.73
  • ALEX $18.48
  • Analyst Decision
  • MNKD Buy
  • ALEX Buy
  • Analyst Count
  • MNKD 6
  • ALEX 3
  • Target Price
  • MNKD $9.17
  • ALEX $23.00
  • AVG Volume (30 Days)
  • MNKD 3.1M
  • ALEX 391.6K
  • Earning Date
  • MNKD 08-06-2025
  • ALEX 07-24-2025
  • Dividend Yield
  • MNKD N/A
  • ALEX 4.87%
  • EPS Growth
  • MNKD 149.32
  • ALEX 94.65
  • EPS
  • MNKD 0.11
  • ALEX 1.07
  • Revenue
  • MNKD $301,736,000.00
  • ALEX $238,308,000.00
  • Revenue This Year
  • MNKD $13.62
  • ALEX N/A
  • Revenue Next Year
  • MNKD $15.18
  • ALEX $1.76
  • P/E Ratio
  • MNKD $34.33
  • ALEX $17.22
  • Revenue Growth
  • MNKD 21.48
  • ALEX 8.21
  • 52 Week Low
  • MNKD $3.38
  • ALEX $15.70
  • 52 Week High
  • MNKD $7.63
  • ALEX $20.11
  • Technical
  • Relative Strength Index (RSI)
  • MNKD 48.69
  • ALEX 58.08
  • Support Level
  • MNKD $3.60
  • ALEX $18.06
  • Resistance Level
  • MNKD $3.81
  • ALEX $18.69
  • Average True Range (ATR)
  • MNKD 0.17
  • ALEX 0.26
  • MACD
  • MNKD -0.00
  • ALEX 0.03
  • Stochastic Oscillator
  • MNKD 50.72
  • ALEX 73.42

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

About ALEX Alexander & Baldwin Inc. REIT Holding Company

Alexander & Baldwin Inc is a Hawaii commercial real estate company. The group owns, operates, and manages million square feet of retail, industrial, and office space in Hawaii. It is a real estate investment trust (REIT) and the owner of grocery and drug-anchored retail centers in the state. It functions through two segments namely Commercial Real Estate and Land Operations. The Commercial Real Estate segment owns and manages retail, industrial spaces, and also urban ground leases in Hawaii, thereby accounting for a majority of the company's revenue. The Land Operations segment actively manages the company's land and real estate-related assets and makes optimum utilization of these assets. Geographically, the activities are carried out across the United States.

Share on Social Networks: